These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35259715)
1. Evaluation of optic nerve diameters in individuals with neurofibromatosis and comparison of normative values in different pediatric age groups. Tosun M; Güngör M; Uslu H; Anık Y Clin Imaging; 2022 May; 85():83-88. PubMed ID: 35259715 [TBL] [Abstract][Full Text] [Related]
2. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma. Eid H; Crevier-Sorbo G; Aldraihem A; Menegotto F; Wilson N AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560 [TBL] [Abstract][Full Text] [Related]
8. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma. Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895 [TBL] [Abstract][Full Text] [Related]
9. Myopia associated with optic nerve gliomas in neurofibromatosis type 1. de Alba Campomanes AG; Avery RA; Prasad S; Liu GT J AAPOS; 2012 Feb; 16(1):89-91. PubMed ID: 22370674 [TBL] [Abstract][Full Text] [Related]
10. The Use of Magnetic Resonance Imaging Screening for Optic Pathway Gliomas in Children with Neurofibromatosis Type 1. Prada CE; Hufnagel RB; Hummel TR; Lovell AM; Hopkin RJ; Saal HM; Schorry EK J Pediatr; 2015 Oct; 167(4):851-856.e1. PubMed ID: 26233602 [TBL] [Abstract][Full Text] [Related]
14. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening. Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105 [TBL] [Abstract][Full Text] [Related]
15. Comparison of multi-shot and single shot echo-planar diffusion tensor techniques for the optic pathway in patients with neurofibromatosis type 1. Ho CY; Deardorff R; Kralik SF; West JD; Wu YC; Shih CS Neuroradiology; 2019 Apr; 61(4):431-441. PubMed ID: 30684113 [TBL] [Abstract][Full Text] [Related]
16. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital. Rony C; Aharoni S; Halevy A Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604 [TBL] [Abstract][Full Text] [Related]
17. Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI. Saraç Ö; Alğin O; Beyazal M; Anlar FB; Varan A; Kansu AT Turk J Med Sci; 2019 Dec; 49(6):1626-1633. PubMed ID: 31655505 [TBL] [Abstract][Full Text] [Related]
18. Neurofibromatosis 1-associated optic pathway gliomas. Shofty B; Ben Sira L; Constantini S Childs Nerv Syst; 2020 Oct; 36(10):2351-2361. PubMed ID: 32524182 [TBL] [Abstract][Full Text] [Related]
19. Prechiasmatic transection of the optic nerve in optic nerve glioma: technical description and surgical outcome. Borghei-Razavi H; Shibao S; Schick U Neurosurg Rev; 2017 Jan; 40(1):135-141. PubMed ID: 27230830 [TBL] [Abstract][Full Text] [Related]
20. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing? Wolsey DH; Larson SA; Creel D; Hoffman R J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]